Harvard Bioscience Shares Slide 5.73 Percent on Lackluster Q4 Results

Mar 03, 2006

NEW YORK, March 3 (GenomeWeb News) - Shares in Harvard Bioscience were down 5.73 percent,or $.30, at $4.94 in afternoon trade after the company late yesterday reported marginal fourth-quarter revenue gains and a $8.9-million loss.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Science Power and Research Fraud

The New York Times reports that as China invests in science, it also is dealing with research fraud.

This Week in PLOS

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

Tianyuan Man's Genome

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.

Just Spread Out Here

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Main menu